Genelux Corporation Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
GNLX Company Description
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
GNLX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view GNLX Smart Score
Score Breakdown
GNLX Company Description
Show More
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of GNLX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GNLX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on GNLX's company Twitter account
WallStreetBets
Number of mentions of GNLX in WallStreetBets Daily Discussion
GNLX News
Recent insights relating to GNLX
CNBC Recommendations
Recent picks made for GNLX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in GNLX
Corporate Flights
Flights by private jets registered to GNLX
Our Analysis